Unintended clinical consequences of the implementation of a checklist-based, low-dose oxytocin protocol
- PMID: 25217735
- DOI: 10.1055/s-0034-1387932
Unintended clinical consequences of the implementation of a checklist-based, low-dose oxytocin protocol
Abstract
Objective: Standardized oxytocin protocols have been used to improve the safety and quality of obstetric care. We examined rates of chorioamnionitis and labor dystocia requiring cesarean delivery as unintended consequences of the implementation of a low-dose, checklist-based oxytocin protocol.
Study design: We performed a retrospective cohort study of live singleton deliveries that underwent a trial of labor in two 15-month periods, comparing outcomes in those who delivered before to after protocol implementation. Patients and outcomes were identified using a combination of electronic medical records and International Classification of Diseases, 9th Revision, Clinical Modification codes. Time trend analysis was performed to evaluate for secular trends.
Results: A total of 8,717 women were included; 5,077 received oxytocin. Despite an unchanged rate of cesarean deliveries from before to after initiation of the protocol (15.15 vs. 14.75%, p = 0.60), deliveries after protocol implementation were generally characterized by higher rates of chorioamnionitis (7.48 vs. 5.97%, p < 0.001), longer median time from admission to delivery (524 vs. 462 minutes, p < 0.001), more cesarean deliveries performed for labor dystocia (50.62 vs. 40.92%, p < 0.001), and fewer cesarean deliveries performed for fetal distress (32.52 vs. 38.67%, p = 0.02).
Conclusion: Low-dose oxytocin protocols are intended to increase safety, but they may have unintended consequences related to prolonged labor, and should be studied before widespread use.
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.
Similar articles
-
Judicious use of oxytocin augmentation for the management of prolonged labor.Acta Obstet Gynecol Scand. 2016 Mar;95(3):355-61. doi: 10.1111/aogs.12821. Epub 2015 Dec 8. Acta Obstet Gynecol Scand. 2016. PMID: 26576009
-
A comparison of obstetrical outcomes with labor induction agents used at term.J Matern Fetal Neonatal Med. 2014 Apr;27(6):592-6. doi: 10.3109/14767058.2013.831066. Epub 2013 Aug 27. J Matern Fetal Neonatal Med. 2014. PMID: 23919802
-
Recognition and response to electronic fetal heart rate patterns: impact on newborn outcomes and primary cesarean delivery rate in women undergoing induction of labor.Am J Obstet Gynecol. 2015 Apr;212(4):494.e1-6. doi: 10.1016/j.ajog.2014.11.019. Epub 2014 Nov 22. Am J Obstet Gynecol. 2015. PMID: 25460835 Clinical Trial.
-
Maternal and neonatal outcomes after oxytocin augmentation in patients undergoing a trial of labor after prior cesarean delivery.Obstet Gynecol. 1992 Dec;80(6):966-71. Obstet Gynecol. 1992. PMID: 1448265 Review.
-
Epidural analgesia associated with low-dose oxytocin augmentation increases cesarean births: a critical look at the external validity of randomized trials.Am J Obstet Gynecol. 2006 Mar;194(3):809-14. doi: 10.1016/j.ajog.2005.09.014. Am J Obstet Gynecol. 2006. PMID: 16522417 Review.
Cited by
-
Inter-institutional variations in oxytocin augmentation during labour in German university hospitals: a national survey.BMC Pregnancy Childbirth. 2019 Jul 9;19(1):238. doi: 10.1186/s12884-019-2348-x. BMC Pregnancy Childbirth. 2019. PMID: 31288780 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical